IPSC icon

Century Therapeutics
IPSC

Overview Fund Activity

63 hedge funds and large institutions have $69.5M invested in Century Therapeutics in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
24
Reduced
16
Closed
17
Calls
$26K
Puts
$7K
Net Calls
+$19K
Net Calls Change
-$432K

Top Buyers

1
DCM
1
DAFNA Capital Management
California
$4.54M
2
DTC
2
Deep Track Capital
Connecticut
$3.55M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$1.12M
4
NYLIM
4
New York Life Investment Management
New York
$464K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$212K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$18.5M
2
HA
2
HHLR Advisors
Cayman Islands
$0
3
Walleye Capital
3
Walleye Capital
New York
$0
4
Millennium Management
4
Millennium Management
New York
$262K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
76
Cubist Systematic Strategies
Connecticut
– -$39.8K -7,762 Closed
SO
77
STRS Ohio
Ohio
– -$13K -2,700 Closed
PMEF
78
Point72 Middle East FZE
United Arab Emirates
– -$8.95K -1,744 Closed
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
– -$7.32K -1,426 Closed
CS
80
Credit Suisse
Switzerland
– -$5 -1 Closed
1 2 3
4